Study on the conditions of the metaiodobenzylguanidine (MIGB) labelled with131I
β Scribed by Chen Daming; Jin Xiaohai; Du Jin; Liu Yuemin; Wang Fan; Bai Hongshen
- Book ID
- 112675810
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 193 KB
- Volume
- 206
- Category
- Article
- ISSN
- 1588-2780
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Eight patients affected by neuroblastoma were treated with 18 courses of 131I-meta-iodobenzylguanidine (MIBG). They all had been judged as "nonresponders" to conventional treatments. Six had stage IV disease: of these, five, with massive marrow involvement, had poor results, mainly because of marrow
I-131-metaiodobenzylguanidine was used for treatment of neuroblastoma stage IV in three children after surgery and or chemotherapy had failed to be effective. In two of the children with multilocular lesions, after an impressive improvement of clinical symptoms tumor progression was observed. Becaus